Bank Of Montreal Theravance Biopharma, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $776,789 - $929,523	93,702 Added 141.04%	160,138 $1.36 Million
Q1 2024 May 13, 2024	BUY	$8.22 - $11.59 $546,103 - $769,993	66,436 New	66,436 $595,000
Q3 2022 Nov 10, 2022	SELL	$8.39 - $10.22 $99,396 - $121,076	-11,847 Reduced 5.45%	205,680 $2.1 Million
Q2 2022 Aug 11, 2022	BUY	$8.41 - $10.34 $1.83 Million - $2.25 Million	217,527 New	217,527 $1.95 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.